Stocks Achieving 52-Week Highs as S&P 500 Surges Over 3% Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Nike Inc. (NYSE:NKE): Up 1.72% to $95.83. ... |
